Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck KGaA Sites

T2Covered by 1 source · first reported by Fierce Biotech / Fierce Healthcare / MedCity / GEN at 04 Nov, 21:34 UTC

The deal would expand Lonza’s U.S. CDMO network from four to nine sites and grow the company’s U.S. workforce nearly 25% by adding approximately 1,100 employees, resulting in a combined headcount of more than 6,000 employees. The post Lonza Expanding U.S. CDMO Footprint with Purchase of Five Merck…